STOCK TITAN

Arvinas (NASDAQ: ARVN) holder files to sell 4,592 Rule 144 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of Arvinas, Inc. has filed a notice to sell 4,592 common shares under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 54607.52. The issuer had 64224294 shares outstanding, and the approximate sale date is 02/13/2026.

The securities were acquired on 02/13/2026 through settlement of vested restricted stock units from Arvinas, Inc., with payment also dated 02/13/2026 and described as not applicable, indicating no separate cash purchase at that time.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for Arvinas (ARVN) disclose?

The filing discloses that a shareholder intends to sell 4,592 Arvinas common shares under Rule 144. The shares are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value reported as 54607.52.

How many Arvinas (ARVN) shares are covered by this planned Rule 144 sale?

The notice covers 4,592 common shares of Arvinas, Inc. to be sold. These shares are listed with an aggregate market value of 54607.52 and are to be transacted on NASDAQ through Morgan Stanley Smith Barney LLC as the broker.

When are the Arvinas (ARVN) shares expected to be sold under this Form 144?

The approximate date of sale is listed as 02/13/2026. On that date, 4,592 common shares are planned for sale on NASDAQ, with Morgan Stanley Smith Barney LLC acting as the broker for the transaction.

How were the Arvinas (ARVN) shares being sold under Rule 144 acquired?

The 4,592 common shares were acquired on 02/13/2026 through settlement of vested restricted stock units from Arvinas, Inc. The filing describes the nature of payment as not applicable, indicating no separate cash payment at acquisition.

What is the reported market value of the Arvinas (ARVN) shares in this Form 144?

The filing reports an aggregate market value of 54607.52 for the 4,592 common shares to be sold. This value reflects the total market amount associated with the planned Rule 144 sale on NASDAQ through Morgan Stanley Smith Barney LLC.

How many Arvinas (ARVN) shares were outstanding relative to this Form 144 sale?

The issuer had 64224294 common shares outstanding according to the filing. The planned Rule 144 sale covers 4,592 of those shares, which are to be sold on NASDAQ with Morgan Stanley Smith Barney LLC as the broker.
Arvinas

NASDAQ:ARVN

ARVN Rankings

ARVN Latest News

ARVN Latest SEC Filings

ARVN Stock Data

748.21M
59.11M
6.85%
94.18%
11.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN